ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,587.00
0.00%
S&P ASX All Technology
2,972.40
0.00%
Brent Oil
83.63
0.11%
US Dollar vs AUD
1.5223
-0.57%
Bitcoin
59,396.50
1.99%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Osiris Therape (MM) (OSIR)

  7. Osiris Therape (MM) (OSIR) News

OSIR

Osiris Therapeutics, Inc. (OSIR)

Osiris Therape (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OSIR
DateTimeSourceHeadlineSymbolCompany
30/04/201906:13Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:OSIROsiris Therape (MM)
17/04/201923:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:19Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:18Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
17/04/201923:05GlobeNewswire Inc.Osiris Therapeutics, Inc. Announces Closing of Acquisition by Smith & Nephew plcNASDAQ:OSIROsiris Therape (MM)
17/04/201920:08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
17/04/201920:08Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
16/04/201923:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
12/04/201922:57Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
10/04/201923:34Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
10/04/201923:30Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
28/03/201908:20Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:OSIROsiris Therape (MM)
28/03/201908:13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:OSIROsiris Therape (MM)
20/03/201922:43Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:OSIROsiris Therape (MM)
20/03/201922:33Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:OSIROsiris Therape (MM)
16/03/201909:13PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
16/03/201900:03Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSIROsiris Therape (MM)
13/03/201908:10Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
13/03/201908:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSIROsiris Therape (MM)
13/03/201908:03Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:OSIROsiris Therape (MM)
13/03/201904:14PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
13/03/201900:33PR Newswire (US)Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.NASDAQ:OSIROsiris Therape (MM)
13/03/201900:22Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:OSIROsiris Therape (MM)
 Showing the most relevant articles for your search:NASDAQ:OSIR

Your Recent History

ASX
RIO
Rio Tinto
ASX
MQG
Macquarie
NASDAQ
AMZN
Amazon.com
NASDAQ
TSLA
Tesla
NYSE
NKE
Nike
ASX
CSL
CSL
ASX
ORG
Origin Energy
ASX
TLS
Telstra
ASX
AMP
AMP
ASX
XTO
S&P ASX 100
ASX
BHP
BHP
NYSE
JPM
JP Morgan Chase
ASX
ANZ
Australia And New Zealan...
FX
AUDCAD
AUD vs CAD
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved